Analgesia in Knee Arthroscopic Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Postoperative Pain
Interventions
DRUG

Dexamethasone

patients will receive intra-articular 8 mg dexamethasone added to 18 mL 0.25% bupivacaine into the knee joint.

DRUG

Dexmedetomidine

patients will receive intra-articular 1ug/kg dexmedetomidine added to 18 mL 0.25% bupivacaine into the knee joint.

DRUG

Saline

patients will receive intra-articular 18 mL 0.25% bupivacaine and 2mL isotonic saline into the knee joint.

Trial Locations (1)

71111

Seham Mohamed Moeen Ibrahim, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02818985 - Analgesia in Knee Arthroscopic Surgery | Biotech Hunter | Biotech Hunter